{
  "pdfPath": "/home/arkantu/Documentos/Zotero Biblioteca/Neurología/Clinical practice/Clinical Reasoning/Biotti et al. - 2014 - Clinical Reasoning A young woman with rapid mental deterioration and leukoencephalopathy A treatabl.pdf",
  "fileName": "Biotti et al. - 2014 - Clinical Reasoning A young woman with rapid mental deterioration and leukoencephalopathy A treatabl.pdf",
  "relativePath": "Neurología/Clinical practice/Clinical Reasoning/Biotti et al. - 2014 - Clinical Reasoning A young woman with rapid mental deterioration and leukoencephalopathy A treatabl.pdf",
  "text": "RESIDENT\n              & FELLOW\n              SECTION\n                          Clinical Reasoning:\nSection Editor\n                          A young woman with rapid mental\nMitchell S.V. Elkind,\nMD, MS                    deterioration and leukoencephalopathy\n                          A treatable cause\n\nDamien Biotti, MD         SECTION 1                                                                          found a marked flaccid paraparesis with urinary and\nMaud Esteban-Mader,       A 21-year-old woman was admitted due to rapid                                      fecal incontinence. Reflexes were all abolished, in\n   MD                     worsening of mental deterioration, which led to her                                contrast to the presence of a bilateral Babinski sign.\nEric Diot, MD             becoming bedridden for over 3 months. She was born                                 Funduscopy was normal. The rest of the examination\nCécile Acquaviva, PhD     to consanguineous parents and had mild mental retar-                               was normal.\nNathalie Guffon, MD       dation and spastic paraparesis that impaired running.                                  A new brain MRI was performed, revealing a sym-\nCaroline Tilikete, PhD    She became pregnant 4 months before admission.                                     metric, confluent, supratentorial leukoencephalopa-\nJean-François Benoist,    During the first weeks of pregnancy she developed                                  thy (figure, C). Lesions were not enhanced by\n   PhD                    deep vein thrombosis, which was treated with antico-                               gadolinium injection. Caudate nuclei appeared hyper-\nPierre Labauge, MD, PhD   agulant therapy. A medical abortion using misopros-                                intense in diffusion-weighted images (figure, D) asso-\nAlain Vighetto, MD        tol and mifepristone was performed. Since this event,                              ciated with a decreased diffusion on the apparent\n                          mental changes progressed rapidly. She had a brain                                 diffusion coefficient map (not shown). Compared to\n                          MRI showing multifocal T2 white matter signal                                      the previous MRI, white matter high intensities had\nCorrespondence to         changes (figure, A and B). A diagnosis of psychosis                                increased.\nDr. Biotti:\ndbiotti@hotmail.com\n                          was considered.\n                                                                                                             Question for consideration:\n                              At admission 3 months later, she was bedridden,\n                          confused, uncooperative, and aggressive. She com-                                  1. What do you think about this clinical and radio-\n                          plained of visual trouble. Neurologic examination                                     logic presentation? How would you investigate it?\n\n\n\n\n                                                                                                                                                             GO TO SECTION 2\n\n\n\n\n                          From the Departments of Neurology (D.B., M.E.-M., C.T., A.V.) and Neuro-ophthalmology (D.B., C.T., A.V.), Hôpital Neurologique Pierre\n                          Wertheimer, Lyon; Université de Lyon 1 (D.B., C.T., A.V.), Université Claude Bernard; Department of Neurology (E.D.), Centre Hospitalier de\n                          Vienne; Service des Maladies Héréditaires du Métabolisme et Centre de Référence des Maladies Héréditaires du Métabolisme (C.A., N.G.), HFME,\n                          Lyon; Service de Biochimie-Hormonologie (J.-F.B.), APHP–Hôpital Robert Debré, Paris; and Service de Neurologie (P.L.), CHRU Gui-de-\n                          Chauliac, Montpellier, France.\n                          Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.\n\ne182                      © 2014 American Academy of Neurology\n\n   ª 2014 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                    Figure      Brain MRI\n\n\n\n\n                  Fluid-attenuated inversion recovery and diffusion-weighted images: 3 months before admission (A, B), at admission (C, D),\n                  and 3 months after treatment onset (E, F).\n\n\n\n                  SECTION 2                                                         Biological testing for acquired leukoencephalopathy\n                  This patient presented with rapid deterioration of            included blood count, sedimentation rate, C-reactive\n                  mental state that could be consistent with a psychiatric      protein and fibrinogen, antinuclear antibodies, anti–\n                  origin. Symptoms occurred after a peripartum deep             extractable nuclear antigens, anti-double-stranded\n                  vein thrombosis leading to an abortion. Three features        DNA, antineutrophil cytoplasmic antibody, antiphos-\n                  were contrary to a psychiatric disease. (1) Neurologic        pholipids, antiB2GP1, antineuron (with GAD65),\n                  evaluation was abnormal, showing a simultaneous               intrinsic factor antibody, vitamins B1, B6, B12, folic\n                  bilateral Babinski sign and loss of deep tendon reflexes.     acid, and biotin, lactate, ammonia, copper, thyroid-\n                  (2) Brain MRI demonstrated an obvious progression of          stimulating hormone, T3, T4, antithyroglobulin, and\n                  the white matter lesions, from patchy T2 white matter         antithyroperoxidase. Blood tests for Lyme disease, viral\n                  hyperintensities to a confluent and symmetric supra-          hepatitis, HIV, human T-cell lymphotropic virus,\n                  tentorial leukoencephalopathy. (3) The patient was            syphilis, and toxoplasmosis were verified. All were\n                  born to consanguineous parents and displayed mental           within normal values or negative. CSF analysis was\n                  retardation and difficulty walking since infancy. This        unremarkable; oligoclonal bands were absent.\n                  last finding suggested an underlying inborn disorder.             To identify rare inherited diseases, clinicians had\n                      Acquired or inherited causes of leukoencephalopa-         to perform meticulous investigations. Occurrence of\n                  thies have to be considered.                                  neurocutaneous symptoms, visual symptoms, poly-\n                      In this context, investigations have to eliminate         neuropathy, or acute clinical manifestations (stroke-\n                  toxic, metabolic, autoimmune, vascular, and infec-            like, coma, psychiatric symptoms, and seizures),\n                  tious causes of leukoencephalopathy. An inherited             ataxia, and paraparesis had to be searched. Visual\n                  cause had to be kept in mind, notably a possible treat-       symptoms should be assessed by the ophthalmologist\n                  able disease.                                                 to detect in particular early cataract, retinopathy,\n\n                                                                                Neurology 83   November 18, 2014                     e183\n\nª 2014 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                    optic atrophy, or corneal deposits. Peripheral neurop-        metabolism. Plasma and urine amino acids (AA)\n                    athy or myopathy had to be studied by a complete              quantitative analysis, urinary organic acid chro-\n                    EMG examination. EMG revealed, in our case, a                 matography, and total plasma homocysteine\n                    severe 4-limb axonal sensorimotor neuropathy. Oph-            (tHcy) had to be measured. Depending on\n                    thalmologic examination was not contributive and              clinical features and MRI abnormalities, arylsulfa-\n                    the impaired vision was related to a central origin.          tase A deficiency (metachromatic leukodystrophy),\n                       Analysis of the magnetic resonance features had to         a-galactosidase deficiency (Fabry disease), X-linked\n                    be meticulous, including symmetrical aspect, location         adrenoleukodystrophy, mitochondrial diseases, and\n                    of high intensity, selective involvement of the pyram-        peroxisomal diseases can be considered.1 In our\n                    idal pathways, profound gray matter, or U fibers. The         patient, tHcy was elevated and plasma AA revealed\n                    presence of cystic lesions, microbleeds, or diffusion-        high level of homocysteine and cysteine/homocyste-\n                    weighted signal abnormalities had to be examined.             ine disulfide with a decrease of cysteine and methi-\n                    Brain MRI is displayed in the figure, C and D. Spinal         onine (table).\n                    cord MRI was normal.\n                                                                                  Question for consideration:\n                       Inherited causes of leukoencephalopathy had to be\n                    systematically screened. They include aminoacidopa-           1. What do you think about homocysteine level and\n                    thies, organic aciduria, and disorders of homocysteine           AA abnormalities? What would you do next?\n\n\n                                                                                                                      GO TO SECTION 3\n\n\n\n\n                      Table        Biochemical findings\n\n                                                          Admission       Day 5          Day 15       Day 30    Day 55        Day 80\n\n                      Total plasma homocysteine (,15      162             177            52           26        20            26\n                      mmol/L)\n\n                      Homocysteine in urine                               39                                    1             1\n                      (,1 mmol/mol creatinine)\n\n                      MMA in plasma                       24.9                           19.3         3.5                     1.5\n                      (,0.5 mmol/L)\n\n                      MMA in urine                                        2154           327.2                  7.8           19.5\n                      (,5 mmol/mol creatinine)\n\n                      Homocystine (,1 mmol/L)a            12              9              ,1           ,1        ,1            ,1\n\n                      Cysteine/homocysteine disulfide     67              51             22           15        14            19\n                      (,1 mmol/L)a\n\n                      Cysteine (23–42 mmol/L)a            10              20             28           54        43            22\n                                                 a\n                      Methionine (21–39 mmol/L)           14              20             26           24        25            29\n\n                                                          Total plasma\n                                                          homocysteine/\n                                                          homocysteine                                                        Plasma/urine\n                                                          in urine        Macrocytosis   Folic acid   B12       Methioninea   MMA\n\n                      Folic acid deficiency               [               1              Y                      Normal or Y\n\n                      B12 deficiency                      [               1                           Y         Normal or Y   [\n\n                      Cystathionine b-synthase            [                                                     [\n\n                      Methylene-tetra                     [                              Y                      Y\n                      hydrofolate-reductase\n\n                      CblC, D, F, J                       [               1b                                    Normal or Y   [\n\n                      CblE, G                             [               1                                     Normal or Y\n\n                      Transcobalamin II deficiency        [               1                                     Y             [\n\n                      Imerslund-Gräsbeck                  [               1                                     Y             [\n\n                    Abbreviation: MMA 5 methylmalonic acid.\n                    Evolution of biochemical findings under treatment (upper part). Main causes of homocysteinemia: laboratory findings\n                    (lower part).\n                    a\n                      Plasma amino acids quantitative analysis.\n                    b\n                      Possibly absent in adults.\n\n\n\n\ne184                Neurology 83      November 18, 2014\n\n  ª 2014 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                  SECTION 3                                                     During this period, without treatment a lethal out-\n                  The high level of tHcy in this patient is highly signifi-     come is possible due to acute metabolic decompensa-\n                  cant. Several acquired or inherited disorders can             tion, multiorgan involvement, cardiomyopathy, or\n                  cause hyperhomocysteinemia. They include transulfu-           neurologic and developmental complications. In\n                  ration disorders (classical homcystinuria due to cystathi-    adult patients (up to the 5th decade), clinical mani-\n                  onine b-synthase deficiency), remethylation disorders         festations can include isolated progressive cognitive\n                  (MTHFR), B12 and folic acid absorption, and trans-            inflection to subacute or acute decompensation of\n                  portation and intracellular metabolism disorders. Renal       neuropsychiatric disorders, neurologic symptoms\n                  insufficiency or drug toxicity (methotrexate, nitrous         (peripheral neuropathy, combined spinal cord degen-\n                  oxide/oxygen mixture) should systematically be ruled          eration), and thromboembolic events (deep vein\n                  out. To better determine the patient’s dysfunction, bio-      thrombosis).4 Megaloblastic anemia is frequently\n                  chemical tests of urine and blood are needed2 (table).        missing in adults.4,5 Brain MRI abnormalities are fre-\n                      The clinical presentation, the medical history, the       quent and various, from white matter periventricular\n                  rapid apparition of white matter changes in associa-          nonspecific T2 high signal to diffuse leukoencepha-\n                  tion with elevated homocysteine level in blood and            lopathy.2,4,6,7 Diffusion-weighted imaging hyperin-\n                  urine, normal folic acid and B12 vitamin levels, high         tensities involving the heads of caudate nuclei are\n                  methylmalonic acid in blood and urine, and hypome-            unusual in our patient and could be related to cyto-\n                  thioninemia on AA (table) indicate a disorder of early        toxic and myelin edema induced by the underlying\n                  steps in intracellular cobalamin metabolism. This             metabolic dysfunction. This aspect is not pathogno-\n                  clinical and biochemical combination suggests cobal-          monic and has been observed in other inborn errors\n                  amin deficiency with homocystinuria type C, D, F,             of metabolism, such as Alexander, Krabbe, or Cana-\n                  or J, justifying their genetic molecular screening.           van diseases and glutaric aciduria type 1. These dif-\n                      Supplementation with intramuscular hydroxyco-             ferential diagnoses do not match the rest of the\n                  balamin (Dodecavit) was started in association with           radiologic abnormalities or clinical manifestations\n                  per os betaine (Cystadane), folinate, and carnitine           observed in our patient.\n                  (Levocarnil).                                                     Disorders of cobalamin metabolism should be sys-\n                      Three months later, symptoms improved. Cogni-             tematically suspected in patients under age 50 years\n                  tive function was restored except for the persistence of      with combined manifestations of peripheral and cen-\n                  a disinhibited frontal syndrome. Visual symptoms              tral nervous systems. Psychiatric symptoms and possi-\n                  disappeared; urinary incontinence only remained at            ble recessive inheritance reinforces this suspicion.4\n                  night. The patient became able to stand and walk a            Asymptomatic adult subjects have been diagnosed\n                  few steps with assistance. Biochemical findings greatly       among siblings of symptomatic patients.\n                  improved (table) and white matter changes dramati-                In our patient, the first symptoms occurred just\n                  cally decreased (figure, D and E).                            after the beginning of pregnancy, which can be\n                                                                                explained by an induction of oxidative and metabo-\n                  DISCUSSION Several weeks after admission, cobala-             lism stress and hypercatabolism. Normal pregnancies\n                  min deficiency, type D was genetically confirmed              and deliveries have yet to be reported, and genetic\n                  (homozygous mutation [c.748C . T (p.Arg250Ter)2,3]            counseling should be advised.2,8 Similar situations\n                  in MMADHC gene, OMIM:277410).                                 can be observed after surgery, prolonged fasting,\n                      In this patient, occurrence of hyperhomocysteine-         nitrous oxide use, or any event generating acute\n                  mia, associated with an increase of methylmalonic acid        metabolism stress.2,4 Close management of at-risk\n                  and normal B12 level, led to the suspicion of a specific      periods is necessary (optimization of treatments, bio-\n                  disorder of early steps in intracellular cobalamin metab-     chemical monitoring).\n                  olism. This allowed early treatment leading to significant        Lifelong treatment is needed with intramuscular\n                  clinical, biochemical, and radiologic improvement.            high doses (5–10 mg/week) of hydroxycobalamin\n                      The transmission of cobalamin deficiency type C,          (not cyanocobalamin), per os betaine 150 mg/kg/day\n                  D, F, or J is autosomal recessive.2 Type CblC is the          (to improve the conversion of homocysteine to methi-\n                  most frequent and could occur in 1:200,000 births,            onine), folate 15 mg/day (to improve remethylation),\n                  whereas only a few cases of adult-onset CblD are              and carnitine 50–100 mg/kg/day (partial depletion\n                  known.2 The normal B12 level excluded vitamin                 due to methylmalonic aciduria).2,4\n                  B12 deficiency and Imerslund-Gräsbeck syndrome.                   In this case, acquired causes were first ruled out.\n                  Absence of megaloblastic anemia ruled out transco-            The second step focused on inherited causes. A system-\n                  balamin II deficiency.2                                       atic screening for treatable disorders, which should\n                      Symptoms related to CblD disorder overlap those           always include total blood homocysteine levels and\n                  due to CblC with a diagnosis made, in most cases,             AA quantitative analysis, revealed obvious abnormali-\n                  during neonatal screening or in the first years of life.2,4   ties. Additional biochemical tests were performed to\n\n                                                                                Neurology 83   November 18, 2014                 e185\n\nª 2014 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                    explore the hyperhomocysteinemia. Inherited intracel-                    2.   Carrillo-Carrasco N, Adams D, Venditti CP. Disorders of\n                    lular cobalamin metabolism disorders type CblC, D, F,                         intracellular cobalamin metabolism. In: Pagon RA,\n                                                                                                  Adam MP, Ardinger HH, et al, eds. GeneReviews®. Seattle:\n                    or J were quickly considered. Genetic molecular testing\n                                                                                                  University of Washington; 1993.\n                    confirmed cobalamin deficiency, type CblD.                               3.   Coelho D, Suormala T, Stucki M, et al. Gene identification\n                                                                                                  for the cblD defect of vitamin B12 metabolism. N Engl J\n                    AUTHOR CONTRIBUTIONS\n                                                                                                  Med 2008;358:1454–1464.\n                    D. Biotti: first author, corresponding author, principal investigator.\n                                                                                             4.   Thauvin-Robinet C, Roze E. Cobalamin metabolism disor-\n                    M. Esteban, C. Tilikete, E. Diot, and A. Vighetto: neurologic manage-\n                    ment. P. Labauge: genetic and neurologic advisor. C. Acquaviva,               ders in adult patients [in French]. Rev Neurol 2007;163:\n                    N. Guffon: biochemical investigations and therapeutics. J.-F. Benoist:        911–918.\n                    genetic testing.                                                         5.   Roze E, Gervais D, Demeret S, et al. Neuropsychiatric\n                                                                                                  disturbances in presumed late-onset cobalamin C disease.\n                    STUDY FUNDING                                                                 Arch Neurol 2003;60:1457–1462.\n                    No targeted funding reported.                                            6.   Longo D, Fariello G, Dionisi-Vici C, et al. MRI and\n                                                                                                  1\n                                                                                                    H-MRS findings in early-onset cobalamin C/D defect.\n                    DISCLOSURE                                                                    Neuropediatrics 2005;36:366–372.\n                    The authors report no disclosures relevant to the manuscript. Go to      7.   Rossi A, Cerone R, Biancheri R, et al. Early-onset combined\n                    Neurology.org for full disclosures.                                           methylmalonic aciduria and homocystinuria: neuroradio-\n                                                                                                  logic findings. AJNR Am J Neuroradiol 2001;22:554–563.\n                    REFERENCES                                                               8.   Brunel-Guitton C, Costa T, Mitchell GA, Lambert M.\n                    1. Saudubray JM, Sedel F. Inborn errors of metabolism in                      Treatment of cobalamin C (cblC) deficiency during preg-\n                       adults [in French]. Ann Endocrinol 2009;70:14–24.                          nancy. J Inherit Metab Dis 2010;33(suppl 3):S409–S412.\n\n\n\n\ne186                Neurology 83      November 18, 2014\n\n  ª 2014 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f       Clinical Reasoning: A young woman with rapid mental deterioration and\n                       leukoencephalopathy: A treatable cause\n                  Damien Biotti, Maud Esteban-Mader, Eric Diot, et al.\n                             Neurology 2014;83;e182-e186\n                         DOI 10.1212/WNL.0000000000001006\n\n                    This information is current as of November 17, 2014\n\n Updated Information &              including high resolution figures, can be found at:\n Services                           http://www.neurology.org/content/83/21/e182.full.html\n\n References                         This article cites 7 articles, 1 of which you can access for free at:\n                                    http://www.neurology.org/content/83/21/e182.full.html##ref-list-1\n Subspecialty Collections           This article, along with others on similar topics, appears in the\n                                    following collection(s):\n                                    All Genetics\n                                    http://www.neurology.org//cgi/collection/all_genetics\n                                    Clinical neurology examination\n                                    http://www.neurology.org//cgi/collection/clinical_neurology_examinati\n                                    on\n                                    Delirium\n                                    http://www.neurology.org//cgi/collection/delirium\n                                    MRI\n                                    http://www.neurology.org//cgi/collection/mri\n Permissions & Licensing            Information about reproducing this article in parts (figures,tables) or in\n                                    its entirety can be found online at:\n                                    http://www.neurology.org/misc/about.xhtml#permissions\n Reprints                           Information about ordering reprints can be found online:\n                                    http://www.neurology.org/misc/addir.xhtml#reprintsus\n\n\n\n\nNeurology ® is the official journal of the American Academy of Neurology. Published continuously since\n1951, it is now a weekly with 48 issues per year. Copyright © 2014 American Academy of Neurology. All\nrights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.",
  "wordCount": 2420,
  "indexed": "2025-09-25T22:53:24.885Z",
  "method": "direct"
}
